Saturday, May 8, 2021
wellness India Expo
Home Tags 2021

Tag: 2021

National policy for rare diseases fails to meet expectations: ORDI

As per Organization for Rare Diseases India (ORDI), the National Policy for Rare Diseases, 2021 abridges the ‘right to health’ by ignoring the true needs of rare disease community in India......................

Industry discusses emerging trends at BioPharma World. IE 2021

Guest of Honour Kris Gopalakrishnan, Chairman, Axilor Ventures & Co-Founder; Infosys & Dr. Dinesh Dua, ED, Nectar Lifesciences & Chairman BioPharma World. IE 2021 felicitated the award winners..........................

India’s MedTech industry: Unleashing the next wave of growth

With COVID-19 spotlight on it, the medical devices industry is positioned to capitalize on near-term opportunities and thereby expand its horizons By Rahul Koul New Delhi: The...

India Science Research Fellowship (ISRF) 2021 announced

ISRF Programme is for Afghanistan, Bangladesh, Bhutan, Maldives, Myanmar, Nepal, Sri Lanka, Thailand researchers to work in Indian Universities and Research Institutions. About 128 fellows from these countries have been awarded a fellowship under this programme........................

BioAsia 2021 to discuss COVID-19 challenges & life sciences opportunities

The two-day forum will feature global leaders like Mr. Satya Nadella; Mr. Amitabh Kant; Dr. Soumya Swaminathan; Dr. Peter Marks; Dr. VK Paul; Dr. Richard Hatchet; Dr. Trevor Mundel and among others...............................

What India’s Budget holds for healthcare-focused global investors

Chastened by COVID -19, the all-round emphasis on preventive health and well being in the budget would create several new value chains for several new products and services, writes Sunil Thakur, Partner, Quadria Capital, Asia’s healthcare-focused private equity firm......................

#Budget2021: Health stakeholders hail 137% hike in allocation

The budget allocation of Rs 2,23,846 crore, as per experts, will help in reducing the rural-urban divide and capacity enhancement interventions across the value chain................. 

#Budget2021: Stakeholders welcome Rs 35,000 crore outlay for COVID-19 vaccines

Experts believe that the largest ever allocation in the history of the vaccine industry would catalyze research and development efforts in the area....................

COVID-19 vaccine rollout gets a mega budget outlay of Rs 35,000...

India has two vaccines available and has begun medically safeguarding not only her own citizens against COVID-19 but also those of 100 or more countries..................

#Budget2021: Industry stakeholders list their expectations

New Delhi: The key stakeholders of the bioscience industry have got huge expectations from the budget 2021 all set to be presented by the...